Researchers have revealed the top 10 drugs by annual revenue in 2025. Here, we investigate the indications that necessitate these treatments and the delivery systems they employ.

This webinar provides an overview of the important UV/Vis spectroscopy-relevant changes in both USP and Ph. Eur., taking a closer look at their impact and the solutions available to ensure compliance.

The FDA has approved XARELTO^® (rivaroxaban) to help prevent blood clots in acutely ill medical patients.

A pioneering clinical study will assess the safety, tolerability and effectiveness of CBD in people with Parkinson’s-related psychosis.

Research has revealed that the global female infertility pharmaceutical market will increase to be worth $2.5 billion by the end of the forecast period.